Why the study?
Polycystic ovary syndrome is detected in 25-45% of obesity cases, prompting evaluation of the frequency and structure of metabolic disorders in obese women with PCOS.
Are metabolic disorders more frequent in obese women with PCOS compared to obese women without PCOS and healthy controls?
Are metabolic disorders more frequent in obese women with PCOS compared to obese women without PCOS and healthy controls?
Obese women with PCOS have a significantly higher burden of metabolic and cardiovascular risk factors compared to obese women without PCOS, highlighting the need for early screening.
Answers are grounded in this paper and cite their sources.
Supports closer metabolic monitoring in obese PCOS; cross-sectional data leave open causality and require prospective confirmation.
BACKGROUND: Obesity is considered a global epidemic and is one of the most significant medical and social problems. Research in recent years shows that in 25-45% of cases of obesity, polycystic ovary syndrome (PCOS) is detected. For this reason, the purpose of our study was to study the frequency and structure of metabolic disorders in obese women in combination with PCOS.METHODS: The study included 136 participants. Group 1 included obese women without PCOS (59 patients), and group 2 included obese women with PCOS (45 patients), in the control group - 38 were healthy women. The study included clinical anthropometry with measurement of body weight, height, waist circumference (OT) and hip circumference (OB), followed by calculation of Body Mass Index (BMI) and OT/OB ratio, and measurement of blood pressure (BP). A biochemical blood test was performed, the hormonal status was examined, and an ultrasound examination of the pelvic organs was performed.RESULTS: Among group 2 patients, dyslipidemia, visceral obesity, arterial hypertension, insulin resistance, hyperinsulinemia, and hyperuricemia were significantly more common (P<0.05). Correlations between BMI and triglycerides, testosterone and total cholesterol were found (P<0.05). Obese and PCOS patients had significantly higher levels of C-reactive protein (CRP), fibrinogen, anti-Müllerian hormone (AMH), and hepatic transaminases (P<0.05). Vitamin D deficiency was detected in 13.2% of patients, and insufficiency in 22.7% of patients. There is a statistically significant correlation between the level of 25 (OH)D and indicators of BMI, follicle-stimulating hormone, luteinizing hormone (P<0.05), the level of AMH (P=0.008).СONCLUSIONS: A high frequency of metabolic disorders in obese women in combination with PCOS has been identified, which necessitates early screening, diagnosis and treatment of these disorders to strengthen reproductive health and prevent chronic non-communicable diseases.
No takes yet. Share an insight, caveat, or question.
Болотова et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: